What was the market valuation for endoscopic retrograde-cholangiopancreatography in Germany in 2024?

The market valuation for endoscopic retrograde-cholangiopancreatography in Germany was $114.19 Million in 2024. Read More

What is the projected market valuation for endoscopic retrograde-cholangiopancreatography in Germany by 2035?

The projected market valuation for endoscopic retrograde-cholangiopancreatography in Germany is $319.42 Million by 2035. Read More

Which companies are considered key players in the Germany endoscopic retrograde-cholangiopancreatography market?

Key players in the market include Boston Scientific, Medtronic, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical, Conmed Corporation, Hoya Corporation, and B. Braun Melsungen AG. Read More

What were the revenue figures for the Biliary Stenting procedure segment in 2024?

The revenue figures for the Biliary Stenting procedure segment were between $30.0 Million and $80.0 Million in 2024. Read More

How did the Hospitals & Clinics segment perform in terms of revenue in 2024?

The Hospitals & Clinics segment generated revenue between $70.0 Million and $190.0 Million in 2024. Read More

What is the revenue range for the Pancreatic Duct Stenting procedure segment in 2024?

The revenue range for the Pancreatic Duct Stenting procedure segment was between $15.0 Million and $40.0 Million in 2024. Read More

What applications are included in the endoscopic retrograde-cholangiopancreatography market in Germany?

Applications in the market include Bile Duct, Pancreas, and Others, with revenue figures ranging from $34.19 Million to $125.0 Million for Bile Duct in 2024. Read More

What product segments are present in the Germany endoscopic retrograde-cholangiopancreatography market?

Product segments include Endoscopes, Endotherapy Devices, Catheters, Stents, Balloons, Guiding Wires, Imaging Devices, and Energy Devices. Read More

What was the revenue for the Endotherapy Devices segment in 2024?

The revenue for the Endotherapy Devices segment was between $15.0 Million and $40.0 Million in 2024. Read More

Germany Endoscopic Retrograde Cholangiopancreatography Market

Q: What is the expected CAGR for the endoscopic retrograde-cholangiopancreatography market in Germany during the forecast period 2025 - 2035?

The expected CAGR for the endoscopic retrograde-cholangiopancreatography market in Germany during the forecast period 2025 - 2035 is 9.8%. Read More

ID: MRFR/MED/49838-HCR

200 Pages

Vikita Thakur

Last Updated: April 02, 2026

Germany Endoscopic Retrograde Cholangiopancreatography Market Research Report: Size, Share, Trend Analysis By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers), By Applications (Bile Duct, Pancreas, Others) andBy Product (Endoscopes, Imaging Devices, Energy Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Germany Endoscopic Retrograde Cholangiopancreatography Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Life Sciences, BY Procedure (USD Million) | |
  1. 4.1.1 Biliary Sphincterotomy | |
  2. 4.1.2 Biliary Stenting | |
  3. 4.1.3 Biliary Dilatation | |
  4. 4.1.4 Pancreatic Duct Stenting | |
  5. 4.1.5 Others |
2. 4.2 Life Sciences, BY End User (USD Million) | |
  1. 4.2.1 Hospitals & Clinics | |
  2. 4.2.2 Ambulatory Surgical Centers |
3. 4.3 Life Sciences, BY Application (USD Million) | |
  1. 4.3.1 Bile Duct | |
  2. 4.3.2 Pancreas | |
  3. 4.3.3 Others |
4. 4.4 Life Sciences, BY Product (USD Million) | |
  1. 4.4.1 Endoscopes | |
  2. 4.4.2 Endotherapy Devices | |
  3. 4.4.3 Catheters | |
  4. 4.4.4 Stents | |
  5. 4.4.5 Balloons | |
  6. 4.4.6 Guiding Wires | |
  7. 4.4.7 Others | |
  8. 4.4.8 Imaging Devices | |
  9. 4.4.9 Energy Devices 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Life Sciences | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Olympus Corporation (JP) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Fujifilm Holdings Corporation (JP) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Cook Medical (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Conmed Corporation (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Hoya Corporation (JP) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 B. Braun Melsungen AG (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 GERMANY MARKET ANALYSIS BY PROCEDURE |
6. 6.3 GERMANY MARKET ANALYSIS BY END USER |
7. 6.4 GERMANY MARKET ANALYSIS BY APPLICATION |
8. 6.5 GERMANY MARKET ANALYSIS BY PRODUCT |
9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
15. 6.12 LIFE SCIENCES, BY PROCEDURE, 2024 (% SHARE) |
16. 6.13 LIFE SCIENCES, BY PROCEDURE, 2024 TO 2035 (USD Million) |
17. 6.14 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
18. 6.15 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million) |
19. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
20. 6.17 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
21. 6.18 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE) |
22. 6.19 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Germany Life Sciences Market Segmentation

Life Sciences By Procedure (USD Million, 2025-2035)

Biliary Sphincterotomy
Biliary Stenting
Biliary Dilatation
Pancreatic Duct Stenting
Others

Life Sciences By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers

Life Sciences By Application (USD Million, 2025-2035)

Bile Duct
Pancreas
Others

Life Sciences By Product (USD Million, 2025-2035)

Endoscopes
Endotherapy Devices
Catheters
Stents
Balloons
Guiding Wires
Others
Imaging Devices
Energy Devices

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓